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Krebszellen werden stark vom Krebs-assoziierten Stroma (CAS) beeinflusst. Eine wichtige Kom-
ponente dieses CAS sind die krebsassoziierten Fibroblasten (CAFs), welche das Tumorwachstum 
und die Metastasierung stark fördern. Die Basen-Exzisionsreparatur (BER) ist ein zentraler DNA-
Reparaturmechanismus in Zellen, der für den Erhalt der Genomintegrität mitverantwortlich ist. 
Ein Knockdown (KD) des zentralen BER Proteins XRCC1 führt zu persistierenden DNA-Schä-
den, die eine ATF4-abhängige Stoffwechselumstellung induzieren, die die Nahrungsautarkie bei-
spielsweise durch Autophagie erhöhen könnte. Der Zweck dieser Umprogrammierung nach 
XRCC1 KD ist jedoch noch unklar. In dieser Arbeit zeigen wir, dass XRCC1 KD Fibroblasten 
einen Überlebensvorteil unter Nährstoffmangel haben, der durch die Aktivierung der integrierten 
Stressreaktion mittels Signalisierung von DNA-Schäden vermittelt wird. Dies wiederum erhöht 
die Translation des Stress-Reaktionsfaktors ATF4. Die Autophagie wird jedoch durch XRCC1 
KD nicht erhöht, was darauf hindeutet, dass der beobachtete Überlebensvorteil unabhängig von 
der Autophagie ist. Interessanterweise fanden wir, dass XRCC1 KD zu einer allgemeinen Ab-
nahme des p62-Proteins durch DNA-Schadenssignalisierung mittels ATM führt. Zusammenfas-
send zeigen diese Ergebnisse, wie persistierende DNA-Schäden weitreichende metabolische und 
andere Veränderungen in Fibroblasten auslösen können, welche Relevanz für die Tumorbiologie 
und darüber hinaus haben. 
 






Cancer is strongly influenced by the surrounding cancer-associated stroma (CAS). A prominent 
cellular component of CAS are the cancer-associated fibroblasts (CAFs) which strongly support 
tumour growth and metastasis. Base excision repair (BER) is a centrally important DNA repair 
mechanism in cells responsible for the maintenance of genome integrity. Knockdown (KD) of the 
core BER protein XRCC1 leads to persistent DNA damage, which induces ATF4-dependent met-
abolic rewiring that might increase nutritional self-sufficiency for example through enhancing 
autophagy. However, the rationale for this reprogramming following XRCC1 KD remains enig-
matic. In this thesis, we show that XRCC1 KD fibroblasts have a survival advantage under nutri-
ent starvation that is mediated through activation of the integrated stress response by DNA dam-
age signalling, which in turn increases translation of the stress-response factor ATF4. However, 
autophagy is not increased by XRCC1 KD, suggesting the observed survival advantage to be 
independent of autophagy. Interestingly, we found that XRCC1 KD leads to a general decrease of 
p62 protein through DNA damage signalling by ATM. In summary, these results reveal how per-
sistent DNA damage can trigger far-reaching metabolic and other changes in fibroblasts with rel-
evance for tumour biology and beyond. 
 






AP site abasic site  
APE1 AP-endonuclease 1  
Asn asparagine 
ASNS asparagine synthetase 
Asp aspartate 
ATF4 activating transcription factor 4 
ATM ataxia telangiectasia (A-T) mutated 
BER base excision repair 
CAF cancer-associated fibroblasts 
CAS cancer-associated stroma 
CQ chloroquine diphosphate salt  
DDR DNA damage response 
eiF2α eukaryotic translation initiation factor 2 subunit 1 
FCS foetal calf serum 
GCN2 general control non‐derepressible 2  
H2O2 hydrogen peroxide 
HRI heme‐regulated eIF2α kinase 
ISR integrative stress response  
KD knockdown 
KO knockout 
LC3 microtubule-associated protein 1A/1B-light chain 3 
Lig IIIα DNA ligase III α 
p62/SQSTM1 sequestosome-1 
PC pyruvate carboxylase 
PKR double‐stranded RNA‐dependent protein kinase 
PERK protein kinase RNA-like endoplasmic reticulum kinase 
Pol β DNA polymerase β  
ROS reactive oxygen species 
RT-qPCR quantitative real-time PCR  
SSB DNA single strand break 
TCA tricarboxylic acid  
TGF β transforming growth factor β  





4.1 Cancer and cancer-associated stroma 
“Cancer” is a term that stands for a large group of diseases that can occur anywhere in the body. 
A similarity shared by all different forms of cancer is that the tumour cells are fast growing, ab-
normal cells which are often able to invade the surrounding tissue and metastasise to distant body 
parts 1. By doing so, cancer cells compromise the function of single organs and sometimes even 
the entire body, which can ultimately lead to death. Indeed, cancer is the second leading cause of 
death worldwide; in numbers that translates to about 10 million people that died because of cancer 
in 2020 2. Considering this, further research is really important to better understand the mecha-
nisms behind cancer biology that allows to improve treatments for affected patients.  
Until quite recently, cancer research focused entirely on the abnormally growing tumour cells 
themselves, without paying much attention to the surrounding tissue. However, more recently, 
scientists have started to appreciate the importance of the non-cancerous tissue that surrounds 
cancer cells, termed CAS, that strongly influences cancer growth and metastasis 3,4. CAS is de-
fined as the non-malignant cells and their stroma that is found within and next to the tumours 3,5. 
Among other constituents such as immune cells, angiogenetic vascular cells and extracellular ma-
trix, fibroblasts are an important component of CAS. Unlike normal fibroblasts, these CAFs show 
an activated phenotype similar to what is found during wound healing. Importantly, these CAFs 
are not just quiescent cells, but instead they are able to strongly support tumour growth, inflam-
mation, angiogenesis and metastasis through a wide variety of mechanisms 3,6,7. Hence, cancer 
cells do not manifest the disease alone, but strongly depend on the normal surrounding cells, 
which constitute a major factor for tumour outcome 8. Considering the importance of the CAS and 
especially CAFs for growth and metastasis of tumours, targeting these components is viewed as 
a promising method for the development of novel therapeutic options to treat cancer 7. Such CAF-
focused therapies are thought to optimally complement the existing mostly tumour-cell targeting 
therapeutic approaches. However, the current knowledge regarding CAFs biology is still far from 
complete and warrants further investigation. 
 
4.2 DNA base-excision repair 
Mutations in the DNA are the molecular trigger for the development of most cancers. Such DNA 
mutations are usually caused by DNA damage. DNA damage can arise from different exogenous 
or endogenous sources. Examples for exogenous sources of DNA damage include exposure to 
ionizing radiation, UV light, or harmful chemicals, to name a few. But DNA damage can also 
arise even in the absence of exogenous DNA damaging agents, because the chemical reactivity of 
DNA in the aquatic milieu renders it prone to spontaneous alterations. The combined actions of 
such endogenous and exogenous DNA damaging agents lead to a high level of DNA damage that 
is constantly present in the cells of our body. This also means that, to avoid deleterious mutagenic 
and cytotoxic consequences of DNA damage, the cells need intricate mechanisms to repair such 
DNA lesions in order to maintain their genome integrity 9-11. One of these mechanisms is BER. 
BER is responsible for correcting DNA single strand breaks (SSBs) and small base lesions, which 
are frequently occurring DNA lesions 11,12. BER is a well-studied process that allows the recog-
nition and removal of corrupted bases, and correct sealing of single-strand breaks. BER can 
roughly be divided into three steps: i) damage-specific DNA glycosylases scan the DNA, recog-
nise corrupted bases, and catalyse the excision of such damaged bases, leaving a ‘gap’ in the DNA. 
ii) These ‘gaps’ are further processed by the AP-endonuclease 1 (APE1). APE1 cleaves the DNA 
sugar-phosphate backbone at 5’ to the AP site, thereby generating a SSB, and trims the DNA ends 
so they are chemically compatible with the next step. iii) Finally, a protein complex consisting of 
DNA polymerase β (Pol β), DNA ligase IIIa (Lig III) and XRCC1 is recruited to fill the gap by 
adding missing nucleotides and to seal the DNA ends to create a fully double-stranded DNA 
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again 11,12. Of note, the protein XRCC1 that is involved in this final step does not have any enzy-
matic activity. Rather, XRCC1 acts as scaffold protein that plays a key role in stabilising the Pol β 
and Lig III complex. Thus, in the absence of XRCC1, the levels of Pol β and Lig III are dramati-
cally reduced, which leads to cells that display a deficiency in DNA repair and increased genomic 
instability 12-14. To ensure maintenance of genetic integrity, levels of BER proteins have been 
shown to be tightly adapted to cellular needs – when there is much DNA damage, levels of BER 
components are increased, and when the damage is repaired again, the levels are lowered again to 
baseline 15-18. Accordingly, there is a plethora of reports showing deregulation of XRCC1 levels 
in different types of cancer (reviewed in 11). Furthermore, a knockout (KO) of XRCC1 in the 
whole mouse is embryonically lethal, presumably through accumulation of unrepaired DNA dam-
age, which is not compatible with physiological development 19,20. A brain-specific KO of XRCC1 
in mice (driven by Nestin-Cre) shows age-dependent accumulation of DNA damage, loss of cer-
ebellar interneurons and altered hippocampal homeostasis 21. Finally, biallelic mutation in 
XRCC1 in humans are associated with progressive cerebellar ataxia, ocular motor apraxia and 
peripheral axonal neuropathy 22. 
In summary, BER is a highly important protection shield to safeguard cellular DNA against fre-
quently occurring DNA lesions, and XRCC1 is a key molecule to ensure the proper function of 
BER. 
 
4.3 A connection between cancer-associated fibroblasts and the base-excision repair 
When it comes to understanding CAF biology, one of the key questions is to elucidate the molec-
ular triggers that cause activation of normal fibroblasts into CAFs. If we understand how CAFs 
are activated, this could potentially lead to the development of approaches to hinder this activation 
and thereby curb their tumour-supportive function. So far, it has been shown that inflammatory 
cytokines, such as transforming growth factor β (TGF β) and/or reactive oxygen species (ROS) 
can activate normal fibroblasts and transform them into CAFs 23,24. However, the exact molecular 
mechanism behind these observations remained obscure. Of note, when cells are exposed to ROS, 
one of the most important effects is the generation of oxidative DNA damage 10,11. This suggests 
a possible role for oxidative DNA damage in activation of CAFs. Consistent with this, persistent 
DNA damage, induced through a downregulation of XRCC1 by siRNA in human primary fibro-
blasts, has been shown to induce gene-expression changes that are comparable to those found in 
tumours 13. Furthermore, exposure of normal fibroblasts to the pro-inflammatory cytokine TGF β 
or ROS for an extended period was found to induce a BER deficiency through downregulation of 
XRCC1, suggesting a potential role for decreased BER in the activation of CAFs 25. Accordingly, 
a downregulation of XRCC1 in fibroblasts led to a decreased BER capacity and persistent DNA 
damage, that in turn induced normal fibroblasts to transform into a CAF-like phenotype capable 
of supporting growth and motility of cancer cells in vitro. It was shown that the stress-responsive 
transcription factor ATF4 was at least partially accountable for this reprogramming 13,25. Taken 
together, prolonged exposure to pro-inflammatory cytokines and ROS can induce a deficiency in 
BER through transcriptional down-regulation of XRCC1, which in turn leads to the transfor-
mation of normal fibroblasts into cancer-cell supporting CAFs. 
Given the literature about adaptation of BER enzyme levels to the status of DNA damage in cells 
to ensure timely repair of these lesions 15-18, the observation that prolonged exposure of fibroblasts 
to persistent DNA damaging agents led to a decrease in BER capacity was somewhat counterin-
tuitive. This sparked the question, why these cells would opt to down-regulate XRCC1 under 
stressful circumstances, instead of increasing their BER capacity to be able to combat DNA dam-
age. The Markkanen group has previously shown that knockdown of XRCC1 in primary fibro-
blasts causes a wide-ranging reprogramming of the cellular metabolism including anabolic 
changes 13. Further analysis showed vast adjustments that cause cellular metabolism to shift away 
from the use of the tricarboxylic acid (TCA) cycle and towards the use of the one-carbon cycle or 
the pentose phosphate pathway [Legrand et al, unpublished observations]. Such changes could 
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benefit the cells by bringing about a self-sufficiency that renders them independent of many ex-
ogenous metabolites, such as amino acids, nucleotides and energy. ATF4 was found to be relevant 
for these metabolic changes. ATF4 is a transcription factor that is known as the main effector of 
the integrated stress response (ISR). In this context, during stressful conditions, ATF4 facilitates 
the expression of several genes involved in anabolic metabolism 26. In summary, there is evidence 
suggesting a connection between downregulated BER capacity and a rewiring of the cellular me-
tabolism, but the consequences of this connection remain unclear. 
 
4.4 Autophagy and cancer-associated fibroblasts 
Autophagy is a mechanism relevant for maintaining cellular homeostasis by degrading intracel-
lular compounds inside lysosomes 27. It can be activated in response to a variety of stressful con-
ditions, such as nutrient starvation, damaged organelles and ER stress 28. Autophagy enables the 
cell to maintain its energy status despite a shortage of exogenous nutrients, because degradation 
products can be released from lysosomes and re-used again 29,30. Autophagy usually is categorized 
into three groups, namely macroautophagy, microautophagy and chaperon-mediated autophagy 
(CMA). Of these, macroautophagy (hereinafter autophagy) is the form that is characterised 
best 28,31. In general, the procedure of macroautophagy requires the intracellular formation of a 
double-membrane organelle, the so-called autophagosome, that then fuses with the lysosome. The 
contents of the arising autolysosome are then degraded by lysosomal enzymes 31,32. There is evi-
dence suggesting that ATF4 is involved in the regulation of autophagy by inducing the transcrip-
tion of the essential autophagy gene Map1lc3b 30,33. 
In addition to playing a role in the response of cells to ‘canonical stress’, autophagy was found to 
be relevant for the ‘reverse Warburg effect’. The reverse Warburg effect describes a model where 
cancer cells and CAFs are viewed as two metabolically coupled compartments. Cancer cells are 
thought to induce oxidative stress in the adjacent stroma by secreting hydrogen peroxide what 
leads to mitochondrial dysfunction in CAFs. As a reaction to this, autophagy, mitophagy and 
aerobic glycolysis are activated in CAFs, which then produce nutrients that in turn can feed cancer 
cells 34-37. Hence, autophagy might have an important role in providing CAF-generated nutrients 
for cancer cell growth.  
The monitoring of autophagy can be performed using two different approaches: either by obser-
vation of structures that are directly related to autophagy or the quantification of proteins and 
organelles that are degraded during the process. In both cases, estimation of autophagic activity 
by determining the autophagic flux instead of analysing autophagy-related structures at a certain 
static timepoint is considered to be more accurate 31,32.  
The most prominent marker to monitor autophagic activity is microtubule-associated protein 1 
light chain 3 (LC3). Immediately after translation LC3 is processed into LC3-I. During autophagy, 
LC3-I is conjugated to phosphatidylethanolamine (PE) to form LC3-II, which is then recruited to 
autophagosomal membranes. Finally, when the autophagosome fuses with the lysosome, LC3-II 
gets degraded 38. Thus, the conversion of LC3-I to LC3-II reflects the progression of autophagy 
and the amount of LC3-II the number of autophagosomes present at a given time point. But it is 
important to consider, that in the following step of degradation, LC3-II gets degraded. Hence, 
inhibition of autophagosome degradation causes an accumulation of LC3-II. In addition, LC3-II 
sometimes can be ectopically found on non-autophagic structures. So absolute LC3-II amount 
does not stand for autophagic activity 31,32,39. Instead, it is better to assess the autophagic flux, that 
means measuring lysosome-dependent degradation of LC3-II during a certain time period. This 
is done by measuring LC3-II protein levels of cells treated with an autophagy inhibitor for a de-
fined period of time compared to the level in untreated cells 31. 
Another popular marker to investigate autophagy is observing the degradation of p62, also known 
as sequestosome 1 (SQSTM1) in humans. p62 is a scaffold protein with various functions in other 
processes besides autophagy, for example apoptosis, inflammation, cell survival and tumorigen-
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esis 40. p62 binds directly to LC3, which is thought to be relevant for delivering selective au-
tophagic cargo for degradation by autophagy. Furthermore, p62 is itself degraded by the autoph-
agy process 31,32. Because of this selective degradation, p62 protein levels decrease when autoph-
agy is active and, on the contrary, p62 accumulates when autophagy is inhibited 41. Levels of both 
of these markers - LC3 and p62 - can be monitored by Western blotting. According to literature, 
autophagy could play an important role in response to several stressful conditions such as nutrient 
starvation, damaged organelles and ER stress 28.  
Concluding, autophagy is important to promote cell survival under stressful conditions, including 
nutrient starvation. Furthermore, autophagy has also been implicated in CAFs, and its activity is 
best monitored using the two markers LC3 and p62. 
 
4.5 Roles of p62 apart from autophagy 
p62 is a multidomain protein best known for its role in autophagy, where it acts as an adapter 
protein. But recent research has unveiled that, apart from autophagy, it is also involved in multiple 
other cellular functions such as apoptosis, inflammation, metabolic reprogramming, cell survival, 
cell death, signal transduction and tumorigenesis where it interacts with several key components 
as signalling hub 40,42-44. Out of these, particularly the connection to metabolic reprogramming 
and cell survival is interesting in view of this project. p62 was found to be downregulated in CAS 
of many tumours, and a downregulation of p62 was able to induce transformation of normal fi-
broblasts into CAFs able to support tumour growth 42,45,46. In addition, this downregulation of p62 
in CAFs was found to promote cell survival under nutrient restricted conditions through an up-
regulation of ATF4 47. ATF4 was found to be polyubiquitinated through a p62 dependent mecha-
nism. When  p62 expression is lost, this polyubiquitination of ATF4 is impaired, which leads to 
higher stability and accumulation of ATF4 protein 47,48. This in turn enhances pyruvate carbox-
ylase (PC) expression and upregulates asparagine synthetase (ASNS), which is known as a direct 
transcriptional target of ATF4 49. Altogether this leads to metabolic changes that enhance glucose 
flux into the TCA cycle and the production of non-essential amino acids, such as aspartate (Asp) 
and asparagine (Asn) 47. These changes were found to be relevant under glutamine-deprived con-
ditions, which is interesting since glutamine is often found to be depleted in solid tumours 50-52. 
Taken together p62 is an interesting target involved in CAF biology, that seems to share some 
similarities with XRCC1: deficiency of both can lead to the activation of CAFs and seems to 
provoke metabolic changes that facilitate the survival of these cells under stressed conditions. It 
is however not known whether there exists a connection between XRCC1 and p62.  
 
4.6 Aim of this thesis 
Resent research has started to unveil a central role of CAFs in the biology of cancer development 
and progression. Nevertheless, the exact mechanism that lies behind CAF formation and the ef-
fects of CAFs on cancer cells are not thoroughly understood. We recently showed that prolonged 
exposure to pro-inflammatory cytokines or the downregulation of XRCC1 by siRNA in fibro-
blasts causes the accumulation of persistent DNA damage that leads to the transformation of nor-
mal fibroblasts into CAFs. ATF4 was found to be relevant for this reprogramming and it seemed 
to shift the cellular metabolism towards nutritional self-sufficiency. However, the reason for and 
consequences of this metabolic shift remained unclear. 
Based on this, we formulated the following hypothesis: Could it be that the downregulation of 
BER capacity in fibroblasts upon exposure to a pro-inflammatory CAF-triggering environment 
helps cells to re-wire of their metabolism in a way that allows these cells to become more inde-
pendent of available nutrients?  
Hence, the aim of this work was to i) understand whether downregulation of XRCC1 could en-
hance cellular survival under nutrient restriction, and if so, ii) to investigate whether activation of 
autophagy could be a driving force behind such a survival advantage. 
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5 Material and Methods 
In the following, only the material and methods for the second, unpublished part of this thesis are 
listed. The respective information to accompany the published paper can be found therein (see 
chapter 6.1). 
 
5.1 Cell culture 
TIG-1 primary human fibroblasts were purchased from Coriell. They were cultured under stand-
ard conditions (37 °C, 5% CO2) in Gibco™ DMEM, low glucose, GlutaMAX™ Supplement, 
pyruvate containing 15% foetal calf serum (FCS) if not indicated otherwise. For the experiments 
cells between passage 14 to 20 were used. 
 
5.1.1 siRNA transfection 
One million TIG-1 cells were seeded in 10 cm diameter petri dishes the day before transfection. 
LipofectamineTM RNAiMAX Transfection Reagent (Invitrogen) was used for siRNA delivery ac-
cording to manufacturer’s protocol. siRNAs were purchased from Eurogentec or Thermo Fisher, 
sequences are specified in Table 1. 
An unspecific, nontargeting sequence was used as control to mimic the procedure of transfection 
and to achieve an appropriate level of KD for ATF4 two siRNA sequences were used in combi-
nation. As ASNS was targeted the first time in this research, two independent siRNA sequences 
were used to exclude off-target effects. 
 
siRNA Sequence Manufacturer Reference/ cat. number 
siControl Manufacturer’s proprietary information Eurogentec SR-CL000-005 
siXRCC1-1 5'-AGGGAAGAGGAAGUUGGAU-3' Eurogentec 53 
siXRCC1-3 5'-GCUUGAGUUUUGUACGGUU-3' Eurogentec 13 
siATF4-1 5'-GCCUAGGUCUCUUAGAUGA-3' Eurogentec 13 
siATF4-2 5'-CUGCUUACGUUGCCAUGAU-3' Eurogentec 13 
siPERK 5'-GUGACGAAAUGGAACAAGA-3' ThermoFisher Assay ID s18102 
siASNS-1 5-GGGUAGAGAUACAUAUGGA-3 Eurogentec 54 
siASNS-2 5-UAUGUUGGAUGGUGUGUUU-3′ Eurogentec 54 
Table 1: siRNA used for transfection. 
 
5.1.2 Analysis of autophagic flux 
To assess the autophagic flux in control and XRCC1 KD cells chloroquine diphosphate salt (CQ, 
SigmaAldrich, cat. no. C6628) was used as an inhibitor of autophagy. CQ was dissolved in dH2O 
at a concentration of 20 mM as a stock solution.  
For the assay two dishes with one million TIG-1 cells were seeded, the next day transfection with 
siCon and siXRCC1 was performed and on day three the cells were split to two new dishes. On 
day four the inhibitor treatment was done by removing the media, washing once with filtered PBS 
and adding new medium containing chloroquine at a concentration of 20 μM. Control dishes were 
treated with the same amount of dH2O. After two hours of incubation the cells were collected by 
scraping them of the petri dish in cold PBS. 
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Figure 1: Scheme of experimental setup to investigate the autophagic flux in XRCC1 KD and control cells. 
 
5.1.3 Inhibitor treatment for protein analysis 
For inhibitor treatment ATMi Ku-60019 (ATMi, SigmaAldrich) was dissolved in DMSO at a 
concentration of 10 mM as a stock solution and used at a final concentration of 10 μM.  
One million TIG-1 cells were seeded day before transfection. Every 24 h the medium was changed 
and fresh inhibitor or equivalent amount of DMSO was added. The treatment was started one hour 
after transfection for a total of three days.  
 
 
Figure 2: Scheme of experimental setup to investigate the effect of ATM inhibition on selected protein levels. 
 
5.1.4 siRNA KD for protein analysis 
Four 10 cm dishes with one million cells were seeded. The next day, two dishes were transfected 
with siCon and siXRCC1, the third dish with either pooled siATF4-1 and -2 or siPERK and the 
fourth with a combination of siXRCC1 with siATF4-1 and -2 or siPERK. Three days after trans-
fection, the cells were scraped of the petri dishes in cold PBS to collect them for further analysis. 
 
 
Figure 3: Scheme of experimental setup to investigate the effect of specific KDs on selected protein levels. 
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5.1.5 H2O2 treatment 
For this experiment three 10 cm dishes with TIG-1 fibroblasts were seeded. One of the dishes 
containing 600’000 and the other two containing one million cells. The dishes containing more 
cells were treated with either 25 μM or 50 μM H2O2 for the following three days, the other dish 
was used as control. The medium was changed every time with the treatment.  
 
5.1.6 Cell survival assay 
On day one six 10 cm dishes were seeded in standard medium containing 15% FCS. The day after, 
transfection with siCon, siXRCC1, siASNS-1, siASNS-2 and a combination of siXRCC1 with 
each of the siASNS sequences was done. On the third day the dishes were split to two new dishes 
and to one dish DMEM with low amount of FCS was added, the other one was cultured under 
normal FCS condition. Three days after transfection, pictures of the living cells were taken with 
EVOS® FL Auto Microscope. Right afterwards the cells were collected for further analysis by 
scraping them of the dish in cold PBS. 
 
 
Figure 4: Scheme of experimental setup to investigate the survival advantage of TIG-1 fibroblasts with specific KDs 
under nutrient restricted conditions. 
 
5.2 mRNA isolation and RT-qPCR 
5.2.1 Extraction and quantification of mRNA 
RNeasy® Mini Kit by QIAGEN was used according to manufacturer’s protocol “Purification of 
Total RNA from Animal Cells using Spin Technology” to extract mRNA. 
mRNA quality and yield were measured with Thermo Scientific™ NanoDrop™ 2000/2000c 
Spectrophotometer according to the manufacturer’s protocol. 
 
5.2.2 Reverse transcription 
For reverse transcription 1000 ng of RNA was diluted in dH2O and reverse transcribed with Bio-
Rad iScriptTM cDNA Synthesis Kit according to the manufacturer’s protocol using the LabCycler 
(SensoQuest). Then the cDNA was diluted 1:5 in dH2O and stored at -80°C until further analysis. 
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5.2.3 RT-qPCR 
Quantitative real-time PCR (RT-qPCR) was performed using the KAPA SYBR® FAST One-Step 
RT-qPCR Kit. The samples were run in duplicates, each in a total volume of 10 μl containing 2 μl 
of sample, on the CFX384 Touch™ Real-Time PCR detection system (Bio-Rad). Primers are 
detailed in the following Table 2. 
Relative gene expression was quantified using the comparative CT method, normalising the val-
ues to the housekeeping genes B2M and GAPDH and to the control. The results were expressed 
as fold change in mRNA levels over control cells.  
 
Gene target Sequence Reference 
XRCC1 Fw: 5’-AACACGGACAGTGAGGAACA-3’ 
Rw: 5’-GCTGTGACGTATCGGATGAG-3’ 
13 
ATF4 Fw: 5’-GGGACAGATTGGATGTTGGAGA -3’ 
Rw: 5’-ACCCAACAGGGCATCCAAGT-3’ 
13 
ASNS Fw: 5’-CTGCACGCCCTCTATGACA-3’ 
Rw: 5’-TAAAAGGCAGCCAATCCTTCT-3’ 
55 
P62/ SQSTM1 Fw: 5’-TGCCCAGACTACGACTTGTG-3’ 
Rw: 5’-AGTGTCCGTGTTTCACCTTCC-3’ 
56 
B2M Fw: 5’-ATGTCTCGCTCCGTGGCCTTA-3’ 
Rw: 5’-ATCTTGGGCTGTGACAAAGTC -3’ 
25 
GAPDH Fw: 5’-AGCCACATCGCTCAGACAC-3’ 
Rw: 5’-GCCCAATACGACCAAATCC-3’ 
13 
Table 2: List of primers used for RT-qPCR 
 
5.3 Western blot 
5.3.1 Protein extraction 
Whole cell extracts from collected TIG-1 cells were prepared by adding M-PER™ Mammalian 
Protein Extraction Reagent supplemented with the cOmplete™, Mini, EDTA-free Protease Inhib-
itor Cocktail (Roche) as lysis buffer to the Eppendorf® Tubes containing the cell pellet. The tubes 
were then kept on a rotator wheel for 30 minutes. This was followed by three cycles of sonication 
with Bioruptor® plus, each cycle consisting of 30 sonication followed by 30 seconds pause. To 
separate the protein, the lysate was centrifuged for 20 minutes at 16050 rcf and the supernatant 
was transferred to a new 1.5 ml the Eppendorf® Safe-Lock tube and stored in -80 °C. The whole 
procedure was performed at +4 °C. 
 
5.3.2 Total protein quantification 
The Bradford assay was used according to manufacturer’s protocol. Each sample was measured 
in double and BSA standard solution at a known concentration was used to calculate the amount 
of total protein in each sample. 
 
5.3.3 Gel preparation 
Depending on the experiment 20 to 40 μg of total protein were loaded with the corresponding 
amount of 4x leammli loading buffer. The samples were boiled at 95 °C for 5 minutes and then 
loaded to CriterionTM TGX Stain-FreeTM Precast Gels 4-20% (BioRad). The gel was run with 
PowerPacTM HV (BioRad) at 150 V for 1 hour. 
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5.3.4 Western blotting 
The separated proteins were transferred onto Trans-Blot® TurboTM Midi 0.2 µm Nitrocellulose 
membrane (BioRad) using the Trans-Blot® TurboTM Transfer System (BioRad) with settings for 
mixed molecular weight proteins. After transfer the membrane was blocked with 1:1 Odyssey® 
Blocking Buffer (PBS) in PBS for 1 h at room temperature. 
 
5.3.5 Antibodies and analysis 
After incubation with primary antibody, the membrane was washed three times with PBS con-
taining 0.1% tween and then the corresponding secondary antibody conjugated with Alexa Fluor 
680 or IRDye 800CW (both Li-cor Biosciences) was added.  
Both primary and secondary antibodies were prepared in 1:1 Odyssey® Blocking Buffer (PBS) 
and PBST. 
For detection of the signal the membrane was scanned with Odyssey® CLx and Image StudioTM 
was used for visualisation and to quantify the protein bands. 
 
Antibody Manufacturer, order no. Isotype 
ATM Cell Signaling, #2873 Rabbit monoclonal 
PERK Cell Signaling, #3192 Rabbit monoclonal 
p62/ SQSTM1 Cell Signaling, #5114S Rabbit polyclonal 
LC3A/B Cell Signaling, #4108S Rabbit polyclonal 
Actin SigmaAldrich, MAB1501R Mouse monoclonal 
 
5.4 Statistical analysis and graphical display of results 
All statistical analysis and graphic display were performed with the program GraphPad Prism 
(www.graphpad.com). One-way ANOVA was used, followed by Bonferroni’s Multiple Compar-
ison Test to assess significance between the groups. A statistical significance level of p < 0.05 




6.1 Paper: “Persistent DNA damage triggers activation of the integrated stress re-
sponse to promote cell survival under nutrient restriction” 
BMC Biol. (2020) 18:36 doi: 10.1186/s12915-020-00771-x.  
 
In this paper, we show a previously unappreciated connection between persistent DNA damage 
and the integrated stress response (ISR). Here, chronic DNA damage, which is triggered by a 
decrease in BER capacity or direct exposure to DNA damaging agents, causes a strong metabolic 
reprogramming towards cellular self-sufficiency that promotes cell survival under nutrient re-
striction. 
My contribution to this paper, of which I am second author, was to show that XRCC1 KD TIG-1 
fibroblasts survive better than control cells under serum restriction (Figure 1 A-E). In addition, I 
identified a first hint for a connection to the ISR, because the survival advantage of cells upon 
XRCC1 KD could be rescued completely with a co-KD of ATF4 and XRCC1 (Figure 2 A-E). 
And I also showed that an increase of ATF4 could be observed in both, mRNA and protein levels 
(Figure 2F and Figure 3A). 





























































6.2 Investigating possible mechanisms underlying the XRCC1 KD mediated survival 
advantage in TIG-1 fibroblasts 
Considering the findings presented in the paper shown in chapter 6.1 of this thesis, we next asked 
ourselves how an XRCC1 KD and the following activation of the ISR could confer the cells with 
a survival advantage under nutrient restricted conditions. In other words, what is the mechanism 
that drives the increased survival of XRCC1 KD cells under nutrient restriction. 
 
6.2.1 XRCC1 KD does not increase the autophagic activity of TIG-1 cells 
Our hypothesis was that XRCC1 KD followed by an upregulation of ATF4 could increase the 
autophagic activity in the fibroblasts, which in turn could provide self-sufficiency with respect to 
nutrients in a way that the cells would depend less on exogenous nutrient supply. This hypothesis 
was supported by the fact that ATF4 was already known to play a role in regulation of autoph-
agy 26,33. 
To investigate whether XRCC1 KD cells have a higher autophagic activity than control cells, we 
transfected TIG-1 cells with siCon or siXRCC1 and treated them with chloroquine, a known au-
tophagy inhibitor 32,57. Two hours after addition of the inhibitor, we collected the cells for protein 
analysis (see Figure 1 for a scheme of the experimental setup). To analyse the autophagic flux we 
checked the known markers for autophagy, p62 and LC3, by Western blot. LC3 is present in cells 
in two different forms, LC3-I and LC3-II. LC3-II migrates slightly below LC3-I in a Western blot 
(Figure 5A). When autophagy is active, both LC3-II and p62 are degraded, which reduces their 
protein levels. When such cells are treated with the autophagy inhibitor chloroquine, an increase 
in LC3-II or p62 in comparison to control treated cells is indicative of active autophagy, as the 
two proteins are not degraded anymore through the autophagic pathway (Figure 5A, compare 
lanes + and - chloroquine). Under conditions of increased autophagy, for example during nutrient 
starvation, chloroquine treatment will cause a stronger surge in the levels of LC3-II and p62 (Fig-
ure 5A). Thus, the relative increase of LC3-II and p62 levels after chloroquine treatment with 
respect to control treated cells is indicative of active autophagic flux in these cells 31,58. 
Using this setup, analysis of protein levels of siCon cells treated with chloroquine revealed a clear 
increase in LC3-II compared to control-treated cells (Figure 5B). This suggested that the chloro-
quine treatment was indeed able to block autophagic depletion of LC3-II and that a basal level of 
autophagy was active in siCon cells. A very similar increase in LC3-II levels could be observed 
upon inhibitor treatment of siXRCC1 cells (Figure 5B). Indeed, quantification of LC3-I and 
LC3-II levels clearly showed that there was no difference in the increase of LC3-II upon chloro-
quine treatment between siCon and siXRCC1 treated cells (Figure 5C). These results suggested 
that there was a basal level of autophagy ongoing in both siCon and siXRCC1 cells under the 
conditions used, but the level of autophagy was comparable between these two conditions. Simi-
larly, also the levels of the second autophagy marker p62 increased in the siCon cells upon chlo-
roquine treatment (Figure 5B and D), further supporting the results obtained by LC3-II. Interest-
ingly however, the XRCC1 KD cells displayed a significant decrease in p62 protein level com-
pared to siCon cells under basal, non-chloroquine treated conditions (Figure 5B and D). Surpris-
ingly, these low levels of p62 could not be rescued by inhibitor treatment (Figure 5B and D). 
Hence, the low levels of p62 observed after siXRCC1 treatment were not caused by increased 
autophagy. Taken together, these results further underlined the notion that there was no difference 





Figure 5: Autophagic flux is not increased in siXRCC1 cells. (A) Schematic example for the analysis of the au-
tophagic flux by Western blot. Autophagy induction by nutrient starvation decreases LC3-II and p62 protein levels 
due to their degradation. When autophagy is inhibited by chloroquine, an increase in LC3-II and p62 can be seen, 
because they are not degraded anymore. The autophagic flux is assessed by the relative increase of LC3-II and p62 
protein levels after inhibitor treatment compared to basal conditions. (B) Representative Western blot of the LC3 and 
p62 levels in siCon and siXRCC1 cells treated with dH2O (control) or chloroquine (CQ), respectively. Actin was 
used as loading control. (C) Quantification of LC3-I and LC3-II protein levels as seen in B). Values are presented as 
mean ±SD normalised to actin as loading control from three independent experiments, with the control treatment set 
to 1. The dots represent all individual values of different experiments. (D) Quantification of p62 protein levels as 
seen in B). Values are presented as mean ±SD normalised to actin as loading control from eight independent experi-
ments with the control treatment set to 1. The dots represent all individual values of different experiments. 
 
6.2.2 Analysing the connection between XRCC1 depletion and a decrease in p62 in TIG-1 
cells 
Having found a decrease of p62 protein upon XRCC1 KD that was independent of autophagy 
(Figure 5B and D), and the known involvement of a loss of p62 expression in CAF biology, we 
next wanted to investigate this connection between XRCC1 and p62 more closely.  
 
6.2.2.1 p62 mRNA level in TIG-1 cells is not influenced by XRCC1 KD 
The decrease in p62 protein level mediated by XRCC1 KD could either be due to a transcriptional 
or post-transcriptional decrease of p62. To differentiate between these scenarios, we analysed p62 
mRNA levels after siCon and siXRCC1 treatment by RT-qPCR. For this, we extracted mRNA 
from TIG-1 fibroblasts transfected with siCon or two different siRNA sequences against XRCC1 
(designated siXRCC1-1 and siXRCC1-3). Both siRNA sequences for XRCC1 were efficient in 
down-regulating mRNA levels of XRCC1 (Figure 6), achieving a downregulation of XRCC1 of 
about 70 to 90%. Using this setup, we could not detect any significant difference in p62 mRNA 
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levels between siCon and siXRCC1 KD cells (Figure 6). These results were confirmed in several 
independent repetitions of the experiment (n = 4 for siXRCC1-1 and n = 2 for siXRCC1-3). Hence, 
the decrease in p62 protein levels upon XRCC1 KD was not due to a transcriptional suppression 
of p62 mRNA. 
 
Figure 6: mRNA levels of p62 are not influenced by XRCC1 KD. mRNA levels of indicated genes in siCon and 
siXRCC1 fibroblasts analysed by RT-qPCR. Values were normalised to GAPDH and B2M with the siCon cells set 
to 1. Data are presented as mean ±SD and the dots represent the individual values from independent repetitions of the 
experiment (n = 4 for siXRCC1-1 and n = 2 for siXRCC1-3). 
 
6.2.2.2 The decrease in p62 protein levels in XRCC1 KD cells depends on signalling by ATM 
As the decrease in p62 protein levels after XRCC1 KD was not caused by a decrease in mRNA 
levels, we next decided to investigate the post-transcriptional regulation of p62. In the paper out-
lined in chapter 6.1 (Figure 4), we showed that XRCC1 KD activated the kinase ATM through 
generation of persistent SSBs, which then in turn triggered the activation of the protein kinase 
PERK. Subsequently, PERK phosphorylated eIF2α, which lead to a global decrease in translation 
and at the same time to a preferential increase in translation of a handful of specific stress-response 
proteins, such as ATF4 26,59,60. This led us to hypothesise that the decrease of p62 protein could 
be due to the global suppression in translation brought about by ATM-mediated phosphorylation 
of eIF2α.  
To test this, we assessed the effect of ATM inhibition in siCon and siXRCC1 treated cells on p62 
protein levels by Western blot (see Figure 2 for a scheme of the experiment and Figure 7C for 
treatment validation). As expected, siXRCC1 treated cells showed a marked decrease in p62 levels 
compared to siCon cells (Figure 7A, B). Interestingly, addition of an ATM inhibitor was able to 
completely rescue p62 levels in XRCC1 KD cells (Figure 7A, B). ATM inhibition also led to a 
further increase of p62 in control cells (Figure 7A and B), suggesting that basal activity of ATM 
constantly suppresses p62 levels also under normal conditions. Thus, the decrease in p62 protein 
levels after XRCC1 KD seemd to be mediated through signalling of DNA damage by ATM.  
To investigate, whether the decrease in p62 also depended on PERK, we investigated the effect 
of PERK depletion on p62 protein levels using siRNA against PERK in XRCC1 KD cells. To do 
so, we transfected TIG-1 cells with either siCon, siXRCC1, siPERK or a combination of siXRCC1 
and siPERK (see Figure 3 for a scheme of the experiment and Figure 7F for treatment validation). 
Surprisingly however, PERK KD alone already decreased the levels of p62 to an even greater 
extent as siXRCC1 treatment (Figure 7D and E). Similarly, the combined siXRCC1 and siPERK 
treated cells showed low levels of p62 (Figure 7D and E). Hence, PERK did not seem to play a 
role in the post-transcriptional decrease of p62 upon XRCC1 KD. 
Finally, to understand whether ATF4 as a downstream effector of the integrated stress response 
was involved in the suppression of p62 protein levels upon XRCC1 KD, we assessed the effect of 
ATF4 depletion using siRNA in XRCC1 KD cells (see Figure 3 for a scheme of the experiment 
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and Figure 7I for treatment validation). Similarly to PERK, also ATF4 KD alone already led to 
reduced levels of p62, and was not able to rescue p62 protein levels in cells depleted of XRCC1 
(Figure 7G and H).  
Taken together, these experiments showed that signalling of DNA damage by ATM was involved 
in the decrease of p62 protein levels, but that the suppression of p62 was independent of signalling 
through PERK or ATF4. 
 
 
Figure 7: Analysis of p62 protein level in TIG-1 cells (A) Western blot analysis of p62 in XRCC1 KD and control 
cells treated with ATM inhibitor or an equivalent amount of DMSO. Actin was used as loading control (B) Quantifi-
cation of p62 protein level as seen in A). Values are mean ±SD normalised to actin as loading control. Each dot 
represents an individual value of an experiment, from five independent experiments. (C) Western blot analysis of 
XRCC1 and ATM protein in XRCC1 KD and control cells treated with ATM inhibitor or an equivalent amount of 
DMSO. Actin was used as loading control (D) Western blot analysis of p62 in TIG-1 fibroblasts transfected with 
siCon, siXRCC1, siPERK and a combination of siXRCC1 and siPERK. Actin was used as a loading control. (E) 
Quantification of p62 protein level as seen in D) Values are mean ±SD normalised to actin as loading control. Each 
dot represents an individual value of an experiment, from three independent experiments. (F) Western blot analysis 
of XRCC1 and PERK protein in TIG-1 fibroblasts transfected with siCon, siXRCC1, siPERK and a combination of 
siXRCC1 and siPERK. Tubulin was used as a loading control. (G) Western blot analysis of p62 in TIG-1 fibroblasts 
transfected with siCon, siXRCC1, siATF4 and a combination of siXRCC1 and siATF4. Actin was used as a loading 
control. (H) Quantification of p62 protein level as seen in G) Values are mean ±SD normalised to actin as loading 
control. Each dot represents an individual value of an experiment, from four independent experiments. (I) RT-qPCR 
quantification of XRCC1 and ATF4 mRNA in TIG-1 fibroblasts transfected with siCon, siXRCC1, siATF4 and a 
combination of siXRCC1 and siATF4. Values were normalised to GAPDH and B2M with the siCon cells set to 1. 
 
6.2.2.3 The induction of direct DNA damage through H2O2 causes a decrease in p62 likewise 
Since our data suggested the decrease in p62 protein levels in XRCC1 KD cells to be connected 
to DNA damage signalling through ATM, we wanted to investigate whether the same effect could 
also be achieved by direct induction of DNA damage.  
For this, TIG-1 fibroblasts were chronically exposed to different low doses of hydrogen peroxide 
for a period of 72h and collected for protein analysis. Indeed, cells treated with H2O2 showed a 
significant, dose-dependent decrease in p62 protein levels compared to control (Figure 8A and B).  
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From this we conclude that DNA damage signalling really was involved in inducing a decrease 
of p62 protein levels. 
 
 
Figure 8: p62 protein level in TIG-1 cells treated with H2O2 (A) Western blot analysis of p62 in TIG-1 fibroblasts 
treated with H2O2 or corresponding amount of dH2O. Actin was used as loading control. (B) Quantification of p62 
protein levels as seen in A9. Values are mean ±SD normalised to actin as loading control, the dots represent all 
individual values of different experiments from four independent experiments. 
 
6.2.3 Metabolic reprograming through XRCC1 KD does not depend on ASNS 
The initial question of this part of the project was to investigate the mechanism behind the survival 
advantage of TIG-1 fibroblasts depleted of XRCC1. Since we found XRCC1 KD to be able to 
decrease p62 protein levels, we wanted to investigate whether this could play a role in the in-
creased survival of these cells. In literature, p62 KD in cells was reported to promote cell survival 
under glutamine-deprived conditions through an upregulation of ASNS 47. To test whether the 
same mechanism applied to our XRCC1 KD fibroblasts, we transfected TIG-1 cells with siCon, 
siXRCC1, two different siRNA sequences for ASNS and a combination of each of these se-
quences with siXRCC1 and cultured them in medium containing different amounts of FCS (see 
Figure 4 for a scheme of the experiment).  
 
6.2.3.1 Checking KD efficiency of two different siRNA targeting ASNS 
Since ASNS KD has not been performed before in our lab we first tested the efficiency of two 
different siRNAs. In addition, we investigated the effect of XRCC1 KD on ASNS on transcrip-
tional level. For this we extracted mRNA from cells collected three days after transfection and 
performed RT-qPCR. Both, siASNS-1 and siASNS-2, reach an appropriate downregulation of 
ASNS and the mRNA level was not influenced by the co-KD with XRCC1 (Figure 9). Interest-
ingly, an upregulation of XRCC1 could be seen in the ASNS KD cells and, vice versa, XRCC1 
KD induced an upregulation of ASNS. The reason for such compensatory upregulation remained 





Figure 9: Validation of KD by siRNA. RT-qPCR quantification of XRCC1 and ASNS mRNA level in TIG-1 fibro-
blasts transfected with siRNA as indicated. Values were normalised to GAPDH and B2M with the siCon cells set 
to 1. 
 
6.2.3.2 The survival advantage of XRCC1 KD cells is independent of ASNS 
Once the downregulation was validated and an upregulation of ASNS following XRCC1 KD was 
shown, we investigated the effect of knocking down ASNS alone or in combination with XRCC1 
in view of cell survival under nutrient restricted conditions. We exposed the transfected cells to 
culture medium containing different amounts of FCS and took pictures of the cells 72h after the 
KD to analyse cell density and morphology. When cells were grown in medium containing suffi-
cient amount of FCS, no clear differences in cell number or morphology could be observed (Fig-
ure 10). As expected, in medium containing just 1% FCS XRCC1 KD cells clearly displayed an 
increased cell number compared to the control (Figure 11A and B). However, this increase in cell 
number was still visible when XRCC1 KD was combined with either of the siRNAs against ASNS 
(Figure 11E and F). The ASNS KD alone seemed to have no influence on the cell survival, as 
they looked virtually indistinguishable from control (Figure 11C and D). 
In conclusion, these findings suggest that the survival advantage of XRCC1 KD cells under nu-





Figure 10: No difference in growth of TIG-1 cells at 15% FCS. Representative phase-contrast images of TIG-1 
human fibroblasts from one representative experiment taken on the third day upon transfection with siRNAs as indi-
cated, started with the same number of cells in each condition and split to DMEM medium containing 15% of FCS 




Figure 11: Growth advantage of XRCC1 KD cells is not influenced by siASNS at 1% FCS. Representative 
phase-contrast images of TIG-1 human fibroblasts from one representative experiment taken on the third day upon 
transfection with siRNAs as indicated, started with the same number of cells in each condition and split to DMEM 
medium containing 1% of FCS 24h after transfection. The shown field is randomly chosen on each plate, from one 
out of two independent experiments. 
 
A Con 15%
  siXRCC1 15%
  siASNS-1 15%   siXRCC1   siASNS-1 15%
D siASNS-2 15%   siXRCC1   siASNS-2 15%
A Con 1%
  siXRCC1 1%
  siASNS-1 1%   siXRCC1   siASNS-1 1%




Cancer is a big burden for today’s global health care system. Despite much ongoing research to 
develop new treatments and diagnostic approaches, about 1 in 6 deaths worldwide is due to can-
cer 1. Recent findings have shown that not only the cancer cells themselves are relevant for the 
disease, but also the surrounding CAS plays a pivotal role in cancer biology. Hence, targeting 
CAS is viewed as a promising approach to find new therapies 3,4,7. One prominent cellular com-
ponent within CAS are the CAFs. CAFs are able to strongly support tumour growth and metastasis, 
therefore acting as a major factor in determining the tumour outcome for patients 8.  
It has been shown that CAF formation can be induced by inflammatory cytokines, such as TGF β 
and/or ROS in vitro 23,24. Recently, our group found that exposure of fibroblasts to these agents 
promotes a decrease in XRCC1, which caused persistent DNA damage, due to a lack of BER 
capacity. This in turn led to the transformation of these fibroblasts into CAFs. Accordingly, this 
CAF-reprogramming of fibroblasts could also be observed by just knocking-down XRCC1, sug-
gesting persistent DNA damage as the molecular driver in CAF activation. The reprogramming 
depended at least partly on the integrative stress response through ATF4 upregulation, which 
seemed to shift cellular metabolism towards an increase in nutritional self-sufficiency 13,25. But 
the reason for and the consequences of this metabolic reprogramming were unclear.  
 
7.1 XRCC1 KD imparts TIG-1 fibroblasts with a survival advantage under nutrient 
restriction mediated through ATF4 
Based on the data outlined above, we hypothesised that XRCC1 KD could impart cells with an 
advantage to survive better in conditions of nutrient restriction. Following this hypothesis, we 
confirmed that XRCC1 KD cells really had a survival advantage over control cells (Chapter 6.1 
Figure 1D and E). Moreover, fibroblasts with a combined KD of ATF4 and XRCC1 did not show 
the increased survival anymore. This suggested that the increased survival depended on ATF4 
(Chapter 6.1 Figure 2D and E). We also confirmed that the KD efficiency of the siRNAs was not 
influenced by the different FCS concentrations by assessing mRNA levels of direct targets and 
several downstream targets (Chapter 6.1 Figure 2F).  
The finding that fibroblasts with an accumulation of persistent DNA damage due to a deficiency 
in BER capacity could survive better under nutrient restricted conditions was very promising. 
Previously it was shown that chronic exposure to two agents known to induce CAF activation, 
namely ROS and pro-inflammatory cytokines, lead to persistent DNA damage that was caused by 
a BER decline through downregulation of XRCC1 25. Based on this it was assumed that CAF 
activation should also be triggered by a direct KD of XRCC1 without exposure to DNA damaging 
agents. Indeed, downregulation of XRCC1 alone was enough to trigger the transformation of nor-
mal fibroblasts into CAFs, suggesting persistent DNA damage is crucial for CAF activation 25. 
But still these findings did not explain why cells should lower their BER capacity under stressful 
conditions. One explanation that was put forward was, that these cells could potentially be better 
eliminated by the immune system or be ‘self-removed’ through apoptotic mechanisms 61. How-
ever, fibroblasts are cells that are highly resistant to apoptosis, instead they rather undergo senes-
cence so they can maintain the structure of the extracellular matrix 62. If they would easily undergo 
apoptosis when damaged, this might have devastating effects on tissue integrity. 
Moreover, our lab uncovered a wide-ranging metabolic reprogramming in fibroblasts with a BER 
deficiency mediated through XRCC1 KD (unpublished data). We assumed that these changes 
enables the cells to grow more independent of nutrient supply, as they increase their self-suffi-
ciency. As the findings in our paper (Chapter 6.1) showed that fibroblasts with a BER deficiency 
grew better under nutrient restricted conditions due to an ATF4 mediated reprogramming this 
further supported the functionality of these metabolic changes. Through this reprogramming, the 
fibroblasts might still be able to fulfil their role to provide structure and stability even under stress-
ful circumstances 63.  
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Implications of these results for CAF biology are quite interesting. CAFs are cells located in next 
proximity to rapidly growing cancer cells. Cancer cells are known to be highly proliferative and 
therefore also to display a huge demand for nutrients. Accordingly, they reprogram their metabo-
lism to enhance nutrient uptake as to sustain their growth and survival 42. In addition, it was also 
shown that they influenced the surrounding stroma in a way to increase nutrient delivery towards 
the cancer cells 4,64. Specifically, CAFs rewired their metabolism to recycle the metabolic waste 
of cancer cells and in turn secreted it again to feed the tumour 46,65,66. Thus, it is thought that cancer 
cells use up most of the available nutrients and thereby leave the surrounding CAFs in a nutrient 
starved environment47. Our findings implicated, that the decline in BER capacity found in CAFs 
increased their nutritional self-sufficiency as a physiological response to ensure their survival in 
the stressed environment next to cancer cells. 
The exact mechanisms and the driving forces for this survival advantage under nutrient restriction 
remained still unclear. However, a closer investigation of this phenomenon would be important, 
as the mechanism underlying the increased survival could potentially be used as a target for ther-
apeutic interventions to remove CAFs. Preventing CAFs from surviving in the stressed tumour 
environment would also stop them from supporting cancer growth, which might well improve the 
success of currently used cancer-cell targeted treatments. 
 
7.2 Autophagy is not involved in the XRCC1 KD mediated survival advantage under 
nutrient restricted conditions 
Having established an unexpected connection between BER capacity, persistent DNA damage 
and reprogramming of the cellular metabolism through the integrated stress response factor ATF4, 
we next wanted to investigate possible mechanisms behind the survival advantage of XRCC1 KD 
cells under nutrient restriction. ATF4 is known to be involved in the regulation of autophagy in 
response to several stresses 33,67. An autophagy gene transcriptional program is activated through 
the eIF2α/ATF4 pathway where ATF4 regulates the transcription of a large number of genes in-
volved in the formation, elongation and function of the autophagosome 33. Autophagy is a cellular 
process that involves the lysosomal degradation of cytoplasmic constituents such as proteins and 
organelles 33,68,69. It is known that the degradation products resulting from autophagy can be re-
cycled to provide sources of energy or base material for the synthesis of new macromolecules 70. 
This led us to hypothesise that an increase in autophagy could enhance cellular self-sufficiency. 
By assessing the autophagic flux in control cells and cells depleted of XRCC1 we were able to 
show that there was no significant difference in autophagy (Figure 5B and C). This suggested that 
autophagy is not relevant for the XRCC1 mediated survival advantage, and that another, yet uni-
dentified mechanism imparts cells depleted of XRCC1 with a survival advantage under nutrient 
restriction.  
 
7.3 An unexpected connection between XRCC1 KD and decreased expression of p62 
During the experiments for autophagy assessment, we observed a striking loss of p62 protein in 
XRCC1 KD cells which could not be rescued by inhibiting autophagy (Figure 5). Due to this 
missing response to autophagy inhibition, we assumed that the loss of p62 was independent of 
degradation through autophagy and instead mediated through another mechanism. This finding 
was interesting as p62 was already known to be involved in several processes such as inflamma-
tion, cell death, survival, and metabolic reprogramming, as well as in CAF activation 42,44.  
An analysis of p62 mRNA levels revealed that the loss of p62 was depended on a post-transcrip-
tional mechanism, since we could not see significant differences in p62 mRNA levels in XRCC1 
KD cells compared to control (Figure 6). As we knew from the data presented in our paper (Chap-
ter 6.1) SSBs generated through XRCC1 KD led to ATM-mediated activation of the PERK-
peIF2α-ATF4 pathway. It is a pathway that is known to be part of the ISR and is activated upon 
ER stress 60,71. Phosphorylation of eiF2α results in a global reduction of protein synthesis and at 
the same time to preferential stimulation of translation of specific mRNAs 26,59,60. Therefore, we 
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hypothesised that p62 protein in XRCC1 KD cells could be lower due to the global decrease in 
translation. To understand this, we designed experiments where we sequentially suppressed the 
players involved in the pathway in addition to XRCC1 KD. By inhibiting ATM in XRCC1 KD 
TIG-1 cells we could show a connection of p62 and ATM, as the loss of p62 could be rescued to 
a level that was comparable with the one found in untreated control cells (Figure 7A, B and C). 
However, this rescue could not be achieved by downregulation of PERK or ATF4 together with 
XRCC1 (Figure 7D – I). Based on these findings we assumed that another mechanism than the 
phosphorylation of eIF2α with following suppression of translation must have been relevant for 
the loss of p62 in cells depleted of XRCC1. However, we could not definitely exclude the in-
volvement of peIF2α. Since for a lack of time just the involvement of PERK and ATF4 could be 
excluded, it might still be possible that phosphorylation of eIF2α could be triggered through an-
other mechanism and in turn inhibited global translation, including the one of p62. Four ser-
ine/threonine eIF2α kinases are known to be able to catalyse the phosphorylation of eiF2α, namely 
PKR‐like ER kinase (PERK), double‐stranded RNA‐dependent protein kinase (PKR), heme‐reg-
ulated eIF2α kinase (HRI), and general control non‐derepressible 2 (GCN2) 26. In our paper (chap-
ter 6.1) we could show that the kinase GCN2 was unable to rescue XRCC1 KD-mediated upreg-
ulation of ATF4 protein (chapter 6.1 Figure 3C). As peIF2α is known to induce ATF4 translation 
we could indirectly assume that GCN2 was not involved in phosphorylation of eIF2α triggered 
by XRCC1 KD. An involvement of HRI or PKR was not yet studied. However, PKR is known to 
be activated through double-stranded RNA during viral infection 72 and HRI is predominantly 
expressed in erythroid cells 73, making it rather unlikely that they played a role in connection to 
XRCC1 KD. 
An interesting auxiliary finding was the strong upregulation of p62 protein in TIG-1 cells upon 
ATM inhibition alone (Figure 7A and B). Furthermore, direct induction of DNA damage by DNA 
damaging agents such as H2O2 led to a dose dependent reduction of p62 protein (Figure 8). Hence, 
there was strong evidence that DNA damage signalling was connected to the p62 decrease. In 
literature we found some report of p62 connected to the DNA-damage response (DDR), for a start 
there was evidence that p62 could shuttle between cytoplasmic and nuclear compartments, which 
facilitated its interaction with components of the DNA repair system 74,75. But the exact mecha-
nism how ATM and DNA damage signalling are connected to p62 will still need to be better 
investigated. 
Besides, we could observe the formation of a second smaller band just above the ordinary p62 
band upon ATM inhibition on the Western blot membrane (Figure 7A). This additional band could 
be appeared due to a post-translational modification such as phosphorylation. There is not much 
data available in the topic of p62 post-translational modifications. In one study we found phos-
phorylation of p62 to be able to modulate the nucleocytoplasmic shuttling of p62 75. Another 
group was able to show that p62 phosphorylation was involved in cell cycle regulation in the 
mitotic phase where phosphorylation was promoted by cdk1 76. ATM is known to respond to DNA 
damage, especially double strand breaks and is an upstream initiator of the checkpoint response, 
therefore a connection between ATM and cdk1 with following p62 phosphorylation would be 
feasible 77. 
Further investigations in this topic could help to understand other roles of p62 besides its involve-
ment in autophagy. A wider understanding would also help to define possible mechanisms that 
could provide targets for therapies against CAFs. 
 
7.3.1 The increased survival of XRCC1 KD cells does not depend on upregulation of ASNS 
promoted by p62 deficiency 
Our findings in chapter 6.2.1 suggested that autophagy was unlikely relevant for the increased 
survival of XRCC1 KD cells under nutrient restriction. For this reason we wanted to investigate 
other possible mechanisms.  
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Available data in literature accredited p62 a role in the survival of CAFs under nutrient restriction, 
specifically under glutamine deprived conditions 42,47. Low levels of p62 have been found in CAS 
from prostate and liver cancer, where it promoted CAF-activation 78,79. In addition to increasing 
their own survival, p62 deficient CAFs even promoted survival of adjacent tumour cells 47. As 
mechanism, a p62 mediated upregulation of ATF4, through enhancing its stability was de-
scribed 47,48. This in turn led to enhanced PC expression and upregulation of ASNS which is a 
known downstream target of ATF4 49, which led to a metabolic reprogramming enhancing glucose 
flux into the TCA cycle to facilitate the production of non-essential amino acids, such as Asp and 
Asn 47. Because we could display a loss of p62 protein in TIG-1 fibroblasts depleted of XRCC1 
we were wondering whether this metabolic reprogramming could also be accountable for the in-
creased survival of XRCC1 KD cells. Knocking-down ASNS together with XRCC1 could not 
rescue the phenotype of the increased survival under nutrient restriction found in XRCC1 KD 
cells (Figure 11) even though ASNS was clearly upregulated by XRCC1 KD (Figure 9). This 
suggests that another mechanism mediates the increased survival of TIG-1 cells depleted of 
XRCC1.  
During the survival assays performed for this project we had the impression that the growth ad-
vantage of XRCC1 KD cells differed when FCS lots changed. From literature we knew that FCS 
composition is quite variable depending for example on seasonal and geographical differ-
ences 80,81. Based on this, we suspected specific components within FCS to be relevant for the 
survival advantage of XRCC1 KD cells compared to control. Previous research for instance found 
an upregulation of serine metabolism and an increase in amino acid uptake upon XRCC1 KD 13. 
This metabolic shift might alleviate the decrease in other nutrients. Therefore, it would be neces-
sary to define whether the survival advantage of XRCC1 KD cells under nutrient restriction de-
pended on specific components and if so, what exact components play a role. Based on this the 
future search for the underlying mechanism of XRCC1 KD cells surviving better under nutrient 
restriction could be more target oriented. 
Taken together it would be highly interesting to further investigate the connection of XRCC1 KD 
and the following loss in p62 protein in CAFs, as there is strong evidence for both to support 
cancer growth and a better understanding of this connection could provide new starting points for 
the development of cancer therapies. 
 
7.4 Physiological relevance of XRCC1 downregulation 
In addition to the CAF-centred roles of XRCC1 downregulation discussed until now, there also is 
a potential physiological aspect to it. Under physiological conditions, BER is responsible to main-
tain genome integrity and prevent accumulation of persistent DNA damage, hence requiring tight 
coupling of DNA damage levels to BER enzyme levels 15-18. However, several instances have 
been described in which BER capacity is specifically lowered in certain cell types under physio-
logical - unstressed - circumstances. Examples for this phenomenon include monocytes, neutro-
philic granulocytes, human spermatozoa and terminally differentiated muscle cells 82-85. It has 
been suggested that such a BER deficiency could ‘label’ these cells for removal or apoptosis and 
help the immune system to eliminate these cells 61. At a closer look, such a mechanism would 
seem not very logical. As for example monocytes were found among the cells with a physiological 
BER deficiency, this would mean that all monocytes are collectively targeted for removal by 
apoptosis or by the immune system as a baseline. Such a mechanism would be quite self-defeating, 
as monocytes are important players of the immune system, and represent progenitor cells of mac-
rophages and dendritic cells 82,86,87. While monocytes were shown to lack expression of some 
essential BER proteins such as XRCC1 and ligase IIIα, in contrast, macrophages and dendritic 
cells that derive from such monocytes re-expressed these BER proteins and showed normal BER 
capacity again 88. This suggests that the transient BER deficiency in monocytes has a special bio-
logical function. As one explanation it was speculated that this could provide a regulatory feed-
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back loop, where monocytes are killed by ROS-producing macrophages, thereby preventing ex-
cessive production of new macrophages that would generate too much ROS in the inflamed tis-
sue 88. Moreover, also in neutrophilic granulocytes, that derive from the same progenitor cells as 
monocytes, a decrease of BER capacity was described 84. Interestingly, in these granulocytes the 
BER defect seemed to have only a small effect regarding cell death. This was reasoned with the 
fact that neutrophils anyway just have a lifespan of 1-2 days 89 and it would be detrimental to 
activate energy-consuming DNA repair processes. In addition, the authors speculated that the 
BER deficiency could help the cells to undergo apoptosis once they had finished playing their role 
in defeating infections 84. 
Our finding that persistent DNA damage due to a BER deficiency enhances cell survival under 
stressful conditions such as nutrient restriction could add another, alternative explanation to the 
phenomenon of a (sometimes transient) physiological BER decrease. Based on our findings, low-
ering their BER capacity could help these cells to survive under biological challenging conditions, 
such as in the blood stream for monocytes or in the female reproductive tract for spermatozoa. It 
would be highly interesting to further pursue this hypothesis. 
Taken together, these findings are of relevance and should be further investigated regarding pos-
sible side effects of future therapeutic interventions against CAF activation. If a promising target 
to prevent CAF activation through a BER decline could be found, it should be considered that this 
intervention could bring disadvantages upon other non-cancer-related cells that lower their BER 




The first aim of this project was to understand whether downregulation of XRCC1 could enhance 
cellular survival under nutrient restriction. We could demonstrate a clear survival advantage of 
XRCC1 KD cells under nutrient restricted growth conditions. It was shown that the KD was con-
sistent in all the conditions, validated by RT-qPCR and Western blot. Furthermore, we were able 
to show the relevance of ATF4 for the survival advantage of XRCC1 KD cells under nutrient 
restriction, as a co-knockdown of XRCC1 and ATF4 resulted in a rescue of the observed pheno-
type in XRCC1 KD cells. These findings are of relevance because understanding the mechanism 
that lies underneath the increased survival could provide new possibilities for therapeutic inter-
vention to further improve the efficacy of anti-cancer treatments. Therefore, the second aim of the 
project was to investigate whether activation of autophagy could be a driving force behind such a 
survival advantage. We demonstrated that there was no significant difference in the autophagic 
flux of control and XRCC1 KD cells. This suggested that autophagy is likely not relevant for the 
survival advantage of XRCC1 KD cells under nutrient restriction. As auxiliary interesting finding 
we detected a loss of p62 protein in cells depleted of XRCC1 that depended on DNA damage 
signalling through ATM. Further investigations of the connection between p62 decrease and 
XRCC1 KD could provide a wider understanding of the metabolic changes happening in CAFs 
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